What is it about?
Switching from allopurinol to febuxostat in HD patients reduced serum UA levels, with no changes in other clinical laboratory data in the long term.
Featured Image
Read the Original
This page is a summary of: Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patients, Journal of Pharmaceutical Health Care and Sciences, October 2015, Springer Science + Business Media,
DOI: 10.1186/s40780-015-0028-1.
You can read the full text:
Contributors
The following have contributed to this page
